Sunday 11 October 2026
Export all SNY data to Excel Powerpack
Sanofi
SNY Healthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
40.07
0.16
−0.40%
Follow SNY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
13.46 | 20.08 | 21.19 | 13.80 | 6.59 | 3.74 | 12.95 | 12.01 | 24.17 | 20.11 |
Piotroski F-Score |
7 | 7 | 5 | 8 | 7 | 5 | 5 | 5 | 7 | 8 |
P/S ratio |
2.24 | 2.52 | 2.49 | 2.57 | 1.87 | 1.91 | 2.04 | 2.06 | 2.66 | 2.75 |
Altman Z-Score |
2.50 | 2.58 | 2.73 | 2.79 | 2.62 | 2.87 | 2.51 | 2.25 | 2.87 | 2.52 |
Altman Z″-Score (non-manufacturers) |
3.68 | 4.21 | 4.05 | 4.31 | 4.09 | 4.67 | 3.52 | 3.44 | 4.45 | 3.90 |
P/FCF ratio |
6.36 | 5.88 | 4.84 | 4.76 | 6.77 | 8.02 | 7.33 | 5.77 | 6.34 | 7.58 |
Beneish M-Score |
(2.63) | (2.66) | (2.63) | (2.59) | (2.48) | (2.24) | (2.70) | (2.52) | (2.63) | (2.66) |
P/Operating CF |
9.73 | 12.28 | 11.27 | 11.06 | 19.23 | 28.27 | 24.50 | 25.08 | 13.06 | 12.17 |
Dividend Safety Score |
58 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.46 | 1.43 | 1.56 | 1.55 | 1.62 | 1.58 | 1.90 | 1.61 | 1.65 | 1.65 |
Price to Tangible BV |
25.20 | 9.42 | 183.58 | 32.17 | 0.00 | 461.17 | 0.00 | 0.00 | 19.61 | 14.54 |
EV/Sales |
2.47 | 2.71 | 2.66 | 2.70 | 2.08 | 2.10 | 2.33 | 2.44 | 2.81 | 2.99 |
EV/EBITDA |
13.29 | 15.81 | 13.91 | 12.06 | 6.98 | 7.42 | 7.43 | 11.37 | 16.25 | 15.11 |
EV/Operating CF |
5.02 | 4.93 | 4.44 | 4.73 | 6.66 | 7.71 | 6.72 | 5.33 | 5.10 | 6.16 |
EV/FCF |
7.02 | 6.33 | 5.16 | 5.01 | 7.52 | 8.80 | 8.39 | 6.84 | 6.69 | 8.24 |
Quick Ratio |
0.58 | 0.54 | 0.72 | 0.90 | 0.86 | 1.11 | 0.85 | 0.82 | 1.13 | 1.07 |
Current Ratio |
1.09 | 1.46 | 1.27 | 1.42 | 1.44 | 1.75 | 1.40 | 1.41 | 1.70 | 1.62 |
Net Debt/EBITDA |
0.76 | 0.77 | 0.56 | 0.46 | 0.87 | 0.48 | 1.09 | 1.85 | 0.53 | 0.82 |
Debt/Assets |
14.66% | 12.05% | 12.96% | 15.02% | 16.89% | 19.66% | 21.90% | 22.12% | 15.63% | 17.75% |
Debt/Equity |
0.26 | 0.21 | 0.22 | 0.25 | 0.29 | 0.36 | 0.42 | 0.42 | 0.27 | 0.32 |
Asset Turnover |
0.37 | 0.34 | 0.37 | 0.35 | 0.34 | 0.33 | 0.33 | 0.34 | 0.36 | 0.33 |
Operating CF/Net income |
1.38 | 1.63 | 1.90 | 1.26 | 1.69 | 0.60 | 2.76 | 1.29 | 0.87 | 1.66 |
Capex/Depreciation |
(0.47) | (0.48) | (0.42) | (0.21) | (0.40) | (0.32) | (0.08) | 0.04 | (0.39) | (0.57) |
Interest Coverage |
15.43 | 7.08 | 6.75 | 23.13 | 22.61 | 36.79 | 14.62 | 12.13 | 14.89 | 7.43 |
| 10.69% | 7.31% | 7.32% | 10.97% | 9.57% | 20.34% | 4.62% | 7.50% | 14.70% | 8.11% | |
| 6.16% | 4.29% | 4.32% | 6.40% | 5.39% | 10.94% | 2.44% | 4.16% | 8.34% | 4.54% | |
ROIC |
6.57% | 5.49% | 6.75% | 7.81% | 6.56% | 12.50% | 5.46% | 4.30% | 6.15% | 6.49% |
Return on Tangible Assets |
61.72% | 23.64% | 32.46% | 42.00% | 32.25% | 51.70% | 15.63% | 25.55% | 41.19% | 23.23% |
Average Days of Receivables |
68.81 | 69.24 | 69.35 | 70.75 | 76.21 | 73.17 | 76.98 | 74.27 | 72.75 | 76.88 |
Research and Development Expense of Revenue |
16.79% | 16.70% | 14.49% | 14.77% | 14.53% | 14.80% | 15.99% | 16.52% | 15.11% | 14.90% |
Selling, General and Administrative Expense of Revenue |
20.43% | 20.74% | 23.02% | 23.12% | 24.39% | 25.13% | 26.26% | 27.63% | 27.78% | 27.33% |
Intangible Assets out of Total Assets |
0.53 | 0.50 | 0.58 | 0.56 | 0.58 | 0.55 | 0.54 | 0.59 | 0.53 | 0.49 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.23) | (0.11) | (0.19) | (0.15) | (0.19) | (0.18) | (0.22) | (0.29) | (0.16) | (0.21) |
Graham Number |
51.89 | 42.65 | 41.31 | 50.26 | 72.87 | 94.72 | 48.04 | 0.00 | 32.50 | 33.76 |
Earnings Yield |
7.43% | 4.98% | 4.72% | 7.24% | 15.19% | 26.70% | 7.72% | 8.33% | 4.14% | 4.97% |
Free Cash Flow Yield |
15.73% | 17.01% | 20.68% | 21.03% | 14.78% | 12.47% | 13.64% | 17.34% | 15.77% | 13.20% |
Revenue per Share |
21.65 | 19.15 | 20.08 | 19.10 | 18.50 | 17.03 | 16.86 | 16.89 | 16.28 | 14.93 |
Operating CF per Share |
4.98 | 3.93 | 4.43 | 4.43 | 4.97 | 3.39 | 3.47 | 2.63 | 3.32 | 3.37 |
Capex per Share |
(1.25) | (0.75) | (0.87) | (0.30) | (0.63) | (0.54) | (0.27) | 0.09 | (0.64) | (0.81) |
Free Cash Flow per Share |
3.74 | 3.18 | 3.57 | 4.13 | 4.34 | 2.85 | 3.20 | 2.71 | 2.68 | 2.56 |
Cash per Share |
3.55 | 3.22 | 3.77 | 5.36 | 4.77 | 6.34 | 4.22 | 3.28 | 4.64 | 4.42 |
Shareholders Equity per Share |
33.24 | 33.66 | 32.15 | 31.62 | 32.60 | 28.77 | 26.48 | 27.95 | 26.20 | 24.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.24 | 33.66 | 32.15 | 31.62 | 32.60 | 28.77 | 26.48 | 27.95 | 26.20 | 24.82 |
Free Cash Flow |
9,117.95 | 7,950.19 | 8,927.89 | 10,338.97 | 10,880.97 | 7,142.80 | 8,010.24 | 6,770.67 | 6,734.33 | 6,599.76 |
Working Capital |
2,949.56 | 14,528.28 | 7,008.97 | 10,601.32 | 10,966.15 | 16,511.95 | 9,217.60 | 8,506.74 | 12,314.62 | 11,345.96 |
Capital Expenditures |
(3,044.60) | (1,876.36) | (2,174.34) | (751.22) | (1,567.61) | (1,366.19) | (663.04) | 219.67 | (1,606.16) | (2,073.77) |
Net Current Asset Value |
(27,315.39) | (13,367.18) | (23,205.59) | (18,484.36) | (24,427.46) | (20,194.72) | (28,019.04) | (32,824.71) | (17,198.64) | (22,420.83) |
EV/EBIT |
13.29 | 15.81 | 13.91 | 12.06 | 12.32 | 14.49 | 21.18 | 19.01 | 16.25 | 15.11 |
Capex to Sales |
0.06 | 0.04 | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 | (0.01) | 0.04 | 0.05 |
Price to Operating Income |
12.03 | 14.69 | 13.05 | 11.44 | 11.08 | 13.20 | 18.50 | 16.01 | 15.40 | 13.90 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.56 | 0.36 | 0.47 | 0.35 | 0.33 | 0.39 | 0.77 | 0.44 | 0.38 | 0.33 |
Cash ROIC |
8.23% | 7.25% | 8.29% | 9.18% | 9.25% | 6.28% | 7.67% | 6.33% | 7.08% | 6.89% |
Accounts Receivable Turnover |
5.55 | 5.14 | 5.34 | 5.05 | 5.08 | 4.89 | 4.83 | 5.04 | 5.04 | 4.72 |
Accounts Payable Turnover |
1.79 | 1.77 | 2.04 | 1.99 | 2.17 | 2.31 | 2.25 | 2.41 | 2.63 | 2.63 |
Inventory Turnover |
1.36 | 1.38 | 1.55 | 1.46 | 1.46 | 1.50 | 1.51 | 1.63 | 1.71 | 1.59 |
Average Days of Payables |
205.90 | 208.72 | 187.88 | 181.58 | 184.06 | 158.98 | 161.93 | 160.91 | 145.64 | 146.55 |
Days of Inventory on Hand |
285.70 | 260.68 | 247.83 | 238.80 | 259.57 | 250.76 | 243.64 | 238.66 | 214.27 | 235.06 |
Average Receivables |
9,527.48 | 9,320.47 | 9,409.89 | 9,473.67 | 9,117.36 | 8,723.21 | 8,731.75 | 8,365.15 | 8,123.30 | 8,145.88 |
Average Payables |
8,249.59 | 8,051.02 | 7,554.64 | 7,244.87 | 6,680.02 | 5,999.52 | 5,951.99 | 5,595.05 | 4,995.87 | 4,496.73 |
Average Inventory |
10,880.71 | 10,333.40 | 9,950.88 | 9,875.49 | 9,925.60 | 9,246.88 | 8,891.81 | 8,267.23 | 7,665.41 | 7,431.03 |
Average Assets |
143,583.95 | 140,286.35 | 135,193.15 | 137,886.30 | 136,542.40 | 128,545.40 | 128,918.55 | 122,203.05 | 114,331.65 | 114,723.60 |
Average Common Equity |
82,690.88 | 82,360.65 | 79,826.20 | 80,425.37 | 76,901.70 | 69,166.89 | 67,960.66 | 67,784.68 | 64,863.20 | 64,256.88 |
Columns are period end dates